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We have used the human neuroblastoma cell line SH-SYSY as a model system to investigate the expression and regulation of the receptors for 
brain-dertved neurotrophic factor (BDNF). a member of the nerve growth factor (NGF) family of neurotrophins. We demonstrate that SH-SY5Y 
cells express transcripts encoding the low-affimty NGF receptor (LNGFR) and trkB, the stgnal transducing receptor unit for BDNF. Interaction 
of BDNF with SH-SYSY cells increased the transcrtptton of the c-fos gene, showing that these molecules encode functional BDNF receptors. Our 
findings that differentiating agents such as retmotds and CAMP analogs Increased the expression of LNGFR. but decreased trkB mRNA levels, 
suggest that LNGFR and trkB have different roles during neuronal differentiatton. 
Brain-derived neurotrophic factor: Polymerase chain reactton; Gene expression; Dtfferentiation 
1. INTRODUCTION 
Neurotrophins play an essential role in the growth, 
survival and differentiation of neurons in both the pe- 
ripheral and central nervous system. Brain-derived neu- 
rotrophic factor (BDNF) [l] is a member of the nerve 
growth factor (NGF) [2] family of structurally related 
neurotrophins, which also includes neurotrophin-3 [3] 
and neurotrophin-4/5 [4,5]. BDNF has been shown to 
promote the survival of embryonic neurons in the no- 
dose ganglia and dorsal root ganglia in vivo [6,7] and 
of retinal ganglion cells [8], basal forebrain cholinergic 
neurons [9, lo] and ventral mesencephalic dopaminergic 
neurons [ 10,l l] in vitro. Recent studies have demon- 
strated that BDNF is also a trophic factor for motor 
neurons [12,13]. 
after exposure to BDNF [15-l 81. Activation of trkB by 
BDNF leads to differentiation and proliferation of 
mouse 3T3 fibroblasts [15,16] and rat pheochromocy- 
toma PC 12 cells [ 181 into which the trkB gene has been 
transfected. As demonstrated by in situ hybridization, 
trkB is expressed at multiple sites in the peripheral and 
central nervous systems [19,20]. 
BDNF protects cultured dopaminergic neurons and 
the human dopaminergic neuroblastoma cell line SH- 
SYSY against the neurotoxic effects of I-methyl4- 
phenyl-1,2.3,6-tetrahydro-pyridine. a chemical known 
to cause Parkinson’s disease in humans [11,21]. This 
suggests that dopaminergic neurons and SH-SYSY cells 
contain the essential components for binding and re- 
sponding to BDNF. 
The effects of neurotrophins are mediated by their 
interaction with specific receptors on target cells. All 
neurotrophins bind to a low-affinity receptor (desig- 
nated here as LNGFR for low-affinity NGF receptor) 
with similar affinities in the nanomolar range. The pro- 
tein tyrosine kinases trk, trkB and trkC have been 
shown to be components of the high-affinity neurotro- 
phin receptors and to mediate functional responses to 
neurotrophins [14]. Recent studies have established that 
trkB is an essential component of the high-affinity re- 
ceptor for BDNF and is phosphorylated on tyrosine 
In the present study, we have used cultured SH-SYSY 
neuroblastoma cells as a model to investigate the ex- 
pression and regulation of BDNF receptors. We ana- 
lyzed whether treatment with differentiation agents 
modulates the expression of the BDNF receptors. Using 
reverse transcription combined with the polymerase 
chain reaction (RT-PCR). we found that SH-SY 5Y cells 
express LNGFR and trkB transcripts and functional 
BDNF recepetors. Furthermore, we demonstrate that 
long-term exposure to differentiating agents, such as 
retinoids and CAMP analogs, regulates LNGFR and 
trkB mRNA expression in opposite ways. 
* Correspondmg author. Fax: (41 I (61) 267 3559. 
Ahbrewnwns. BDNF. brain-dertved neurotrophic factor; dbcAMP, 
dtbutyryl cyclic AMP. FCS. fetal calf serum; LNGFR. low-affinity 
NGF receptor. NGF, nerve growth factor; RT-PCR, reverse tran- 
scrtption-polymerase chain reactton. 
2. MATERIALS AND METHODS 
2.1, Matuxlls 
Vitamin A (retinol) and dtbutyryl cychc AMP (dbcAMP) were pur- 
chased from Stgma Restrtctton endonucleases were obtained from 
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Boehringer Mannhelm. Tretinom (All-truns-retmoic acid), tsotreti- 
nom (13.cis-retmoic actd; Ro 4-3780) and acitretin (All- rruns-9-(4- 
methoxy-2,3,6-tr~methylphenyl)-3.7-dlmethyl-2~4,6.8- nonatetraenoic 
acid; Ro 10-1670) were kindly provtded by Dr. W. Bollag (F. 
Hoffmann-La Roche. Base]. Switzerland). Human recombmant 
BDNF was a gtft from Dr. L. Aloe (Institute of Neurobiology. CNR. 
Rome. Italy) The human neuroblastoma cell hne SH-SYSY was ob- 
tamed from Dr. J. Biedler (Sloan Kettering Cancer Research Institute. 
New York, NY. USA). 
TG-3’ and S’-TTGCAGCTGTTCCACCTCTT- 3’. the trkB primers 
were S’-CCGCTAGGATTTGGTGTACT-3’ and S’CCACTGTCA- 
TCAGATGAAAT-3’, the c-fos primers were S’- AGCTATCTCCT- 
GAAGAGGAA-3’ and 5’-AGGCTCCCAGTCTGCTGCAT-3’ and 
the ribosomal protein Sl2 primers were 5’-GGAAGGCATTGCTG- 
CTGG-3’ and S’CTTCAATGACATCCTTGG-3’. The sizes of the 
amplified products were 663 base pairs (bp) for LNGFR. 664 bp for 
trkB. 522 bp for c-fos and 368 bp for Sl2. 
2 2. CeN culture 3. RESULTS 
SH-SY5Y cells were mamtained in supplemented RPM1 1640 
(Seromed) containing 10% fetal calf serum (FCS. Gtbco) at 37°C m 
humidified 5% C02/95% air as described earlier [22]. SH-SYSY cells 
were stimulated as indicated m the respective experiments. Durmg 
stimulation, cells were kept in RPM1 1640 with I% FCS Stock solu- 
tions of retinoids were prepared in 0 1% dimethyl sulfoxide and stored 
in the cold protected from light. Control cultures were treated with an 
equivalent volume of solvent. 
3.1. Espressiotl qf‘ LNGFR and trkB tnRNA in SH- 
S Y5 Y cells 
2.3. RN,4 prepcuation 
Total cellular RNA was isolated by acid guanidmium thtocyanatel 
phenol/chloroform extraction [23] and quantified spectrophotometri- 
tally by absorbance at 260 nm. The integrity of RNA was checked by 
formaldehyde/agarose gel electrophorests. 
2.4. Reverse trurlscrrpiron-poll.merctse CIKIVI reuctm (RT-PCR I 
Total RNA of each sample was first reverse-transcibed mto cDNAs. 
which in turn were subJected to PCR amplification using prtmers 
specific for LNGFR [24]. trkB [19] and c-fos [75] (see below) essen- 
ttally as described previously [26] PCR amplification of a constitu- 
tively expressed control mRNA encoding the rtbosomal protein S12 
[27] was used as a measure of the amount of input RNA. Controls 
using RNA samples without RT or controls without RNA were used 
to demonstrate absence of contaminating DNA. In brief. cDNA was 
synthesized in a final volume of 20@ with the followmg components: 
I fig total RNA, 50 mM Tris-HCl pH 8.3, 3 mM MgCI,, 7.5 mM KCI, 
IO mM dtthtothreitol, 1 mM dNTPs. 100 pmol of random hexamer 
oligonucleotides (Pharmacia). 20 units of RNase mhibttor (Boehrmger 
Mannheim) and 200 units of Moloney Murine Leukemia Virus reverse 
transcrtptase (Bethesda Research Laboratories). The mixture was n- 
cubated at 37°C for 60 mm. followed by 5 mm at 95°C and flash 
cooling to 4°C. 
We have found that unstimulated SH-SYSY cells pro- 
duce LNGFR and trkB transcripts. As shown in Fig. 
IA, PCR amplification with primers specific for 
LNGFR or trkB gave products of the expected size for 
the LNGFR (663 bp) and the trkB mRNA (664 bp), 
respectively. The identity of the trkB PCR product was 
confirmed both by digestion with appropriate restric- 
tion enzymes (PstI and HindIII) and by hybridization 
with a trkB-specific probe. An identical pattern of re- 
striction fragments was obtained for the trkB amplifica- 
tion product from rat neocortex. a brain region known 
to express trkB [20]. and from SH-SYSY cells (Fig. 1B). 
This finding indicates that the trkB transcripts found in 
SH-SYSY cells are similar to those transcribed in vivo. 
3.2. Effect of BDNF 011 cfbs irtductiorl 
PCR was performed m a total volume of 15~1 contammg cDNA 
made from I5 ng of total RNA, I8 mM Tris-HC1 pH 8.3,55 mM KCI. 
0.08 mg/ml gelatine, MgClz either 1.8 mM for LNGFR and trkB or 
1.2 mM for S12. 0.2 mM dNTPs. 0.4 PM each S’- and 3’-primers and 
0.4 unit Taq DNA polymerase (Boehringer Mannhelm) The PCR 
mixture was overlaid with mineral oil (Sigma) and incubated m an 
Ericomp thermal cycler. The amplification steps involved denatura- 
tion at 94°C for I min. annealing for 2 min at 55°C with LNGFR 
primers or 50°C with trkB and S12 primers, and extension at 72°C 
for 3 min. Coamplification of c-fos and S12 was performed as above 
with 1 mM MgClz at an annealing temperature of 55°C. Samples (4~1) 
of the PCR mixtures were analyzed by electrophoresis in I .3% agarose 
gels m the presence of ethidmm bromide (0.5 &ml). followed by 
alkaline blotting of the fragments onto nylon membranes and subse- 
quent hybridization with specific digoxtgenin-labeled DNA probes 
[28]. Detection was wtth AMPPD as chemtluminescent substrate for 
alkaline phosphatase conjugated to anti-dtgoxtgenm antibodies 
(Boehrmger Mannheim). as indicated by the manufacturer. Appropri- 
ate exposures of Kodak X-Omat films were quantified usmg a video 
densitometer (Model 620, Bto-Rad). The results were expressed as the 
ratio of the signal of amplified LNGFR. trkB or c-fos to the signal 
of amplified rtbosomal protein Sl2 The trkB primers were chosen 
from regions outside the tyrosme kinase domam to avotd recognition 
by other members of the tyrosme kmase family of genes. particularly 
the closely related trk and trkC [l4]. The primers used to amplify the 
LNGFR mRNA sequences were 5’-AGCCAACCAGACCGTGTG- 
The trkB primers used in our experiments are located 
in the extracellular domain of the trkB gene and there- 
fore do not distinguish between the two classes of trkB 
transcripts that encode identical extracellular and trans- 
membrane domains. but differ in the intracellular do- 
main by the presence or absence of the catalytic tyrosine 
kinase region [29]. To investigate whether the LNGFRI 
trkB transcripts in SH-SYSY cells encode functional 
BDNF receptors, we have analyzed the induction of the 
immediate-early gene c-fos expression as an indicator of 
responsiveness to BDNF. Fig. 2 shows that c-fos ex- 
pression was induced two-fold in BDNF-stimulated 
SH-SYSY cells as compared to untreated cells, indicat- 
ing that SH-SYSY cells express receptors capable of 
transducing a BDNF signal. 
3.3. ITffhct ofretimids on LNGFR arid trkB tnRNA es- 
pressiori 
To investigate whether retinoids influence the expres- 
sion of BDNF receptors. SH-SYSY cells were exposed 
to vitamin A, known to promote neuroblastoma differ- 
entiation [30]. Treatment of SH-SYSY cells with vita- 
min A induced a marked, dose-dependent increase in 
LNGFR mRNA (Fig. 3A. upper panel and Fig. 3B). 
Maximal induction (3-fold) occurred at a concentration 
of 10 ,uM. In contrast to LNGFR. a decrease in trkB 
transcript levels was observed in vitamin A-treated SH- 
SYSY cells (Fig. 3A, middle panel and Fig. 3B). The 
constitutive expression of mRNA encoding ribosomal 
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Fig. 1. Detection of LNGFR and trkB transcripts m SH-SYSY cells. (A) Total RNA isolated from SH-SYSY cells (lanes 3 and 6) was subjected 
to RT-PCR amplification using specific primers for LNGFR or for trkB. PCR products were electrophoresed through agarose gels, blotted onto 
nylon membranes and probed with chgoxlgenin-labeled DNA probes Total RNA from PC12 cells (lane 1) or from rat neocortex (lane 4) were used 
as positive controls for LNGFR and trkB amphfication. respectively. Lanes 2 and 5, control RT-PCR without RNA. Lanes M, dlgoxigenin-labeled 
DNA molecular size markers VI from Boehringer Mannhelm. (B) RestrictIon enzyme analysis of PCR-generated trkB products. Samples were 
amplified by PCR using trkB primers and treated with restriction enzymes Pstl, which produces fragments of 451, 127 and 86 bp, and HindIII, 
which produces fragments of 519 and 145 bp. RestrictIon fragments were fractionated by electrophoresis on a 1.3% agarose gel and analyzed by 
Southern blotting. RestrictIon fragments smaller than 200 bp could only be detected after overexposure and therefore are not seen on the blot. 
Lanes 1, negative control without RNA; lanes 2, posltlve control. rat neocortex; lanes 3, unstimulated SH-SYSY cells. 
protein S12 observed in all samples (Fig. 3A. lower mRNA (Fig. 4A). As demonstrated in Fig. 4B, these 
panel) confirmed that differences in mRNA levels were retinoids significantly down-regulated trkB mRNA lev- 
due to a specific regulation of the LNGFR and trkB els, in line with the results obtained with vitamin A. At 
genes. Moreover, exposure of SH-SYSY cells to deriva- 10 PM. the retinoid tretinoin elicited the strongest re- 
tives of vitamin A, such as tretinoin, isotretinoin and sponse, followed by vitamin A, isotretinoin and to a 
acitretin. also induced an up-regulation of LNGFR much lesser extent acitretin. 
A B 
M _ + BDNF 
bp 
653 _ 
453 - 4 c-fos 
296-- I.. ‘S12 
- BDNF + BDNF 
Fig. 2. BDNF induces c-fos transcription in SH-SYSY cells. Cells were incubated for 60 min either in the absence or presence of BDNF (100 ng/ml) 
Total RNA was isolated, reverse-transcribed and coamplified for c-fos and control S12 by PCR. (A) Southern blot analysis of PCR products after 
21 cycles of amplification. Lane M is as in Fig. I. (B) Quantttation of c-fos transcripts..“› Values are the ratio of densitometric scores for c-fos and 
S12 PCR products. Results are means + S.E.M. of two independent determmatlons, each done in triplicate. StatistIcal analysis performed with 
Student’s t-test showed significant differences (*I’ < 0 02) between medium alone and medium plus BDNF. 
289 
Volume 330, number 3 FEBS LETTERS September 1993 
A 
dill trkB 
w ‘, 
B 
3- 
2- 
l- 
- LNGFR 
- trkB 
Vitamin A CyM) 
Fig. 3. Effects of vitamin A on the expression of LNGFR and trkB mRNA m SH-SYSY cells Cells were cultured for 72 h in RPM1 1640/l% FCS 
m the presence of the mdlcated concentrations of vitamin A. Total RNA (I pug) was isolated and subjected to RT-PCR as described m Fig. 1 (A) 
Southern blot analysis of LNGFR PCR products after 27 cycles of amplification (upper panel). of trkB after 25 cycles of amphficatlon (middle 
panel) and of control ribosomal protem S13 after 24 cycles of amphfication (louer panel) (B) Quantltatlon of transcripts Value\ are the ratlo of 
densltometric scores for LNGFR or trkB and S12 PCR products Result5 are means ? S E.M of three Independent determmatlons. each done 
m duphcate (*P < 0 002) 
3.4. E&t of dbcAMP on LNGFR und tr_kB Ie\vl.s 
Treatment of SH-SYSY neuroblastoma cells with 
dbcAMP promoted morphologic differentiation (Fig. 5) 
and induced accumulation of LNGFR mRNA. As 
measured by RT-PCR, LNGFR mRNA levels in 
treated SH-SYSY cells were elevated 3-fold compared 
with controls (Fig. 6). In contrast, trkB mRNA levels 
A. 
61 ** 
0.5 IO 0.5 JO 0.5 JO FM 0.5 10 0.5 IO 0.5 10 PM 
Control Tretinoin Jsotretinoin Acitretin Control Tretinoin Isotretinoin Acitretin 
were significantly reduced by treatment with dbcAMP 
(Fig. 6). 
4. DISCUSSION 
In this report, we present evidence that transcripts 
encoding LNGFR and trkB are expressed in SH-SYSY 
IO 
06 
Fig. 4. Effects of vitamin A derivatives on the expression of LNGFR (A) and trkB (B) mRNA m SH-SYSY cells Cells were cultured for 72 h m 
the presence of the indicated concentrations of tretinom, lsotretmoin and acltretm. Total RNA was processed for RT-PCR AS dehcrlbed m 
Fig. I. Results are means ? S E.M. of three Independent determmatlons, each done in duphcate (**P < 0 002: *P < U.03). 
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Fig. 5. Morphology of the human SH-SYSY neuroblastoma cells. 
Cells were plated as described m Materials and Methods and stamed 
accordmg to May-Grdnwald and Glrmsa. (A) Undifferentiated SH- 
SYSY cells. (B) Differentiated SH-SY5Y cells after 5-day treatment 
with dbcAMP (1 mM) Magmfication x 200 
neuroblastoma cells. We demonstrate that SH-SYSY 
cells synthesize functional BDNF receptor since interac- 
tion of BDNF with SH-SYSY cells increased the expres- 
sion of the c-fos gene, whose rapid and transient tran- 
scriptional activation is considered to be a marker for 
BDNF signal transduction. To understand the regula- 
tion of BDNF receptor expression better. SH-SYSY 
cells were exposed to agents, known to shift neuroblas- 
toma cells to different differentiation state [30]. Our 
finding that retinoids and CAMP analogs up-regulated 
LNGFR mRNA, but down-regulated trkB mRNA in 
SH-SYSY cells. points to a significant role of LNGFR 
in differentiated cells. SH-SYSY cells may thus be used 
as model system to study the functional importance of 
the LNGFR. 
Expression of functional BDNF receptors on SH- 
SYSY cells is consistent with data showing that BNDF 
can protect SH-SYSY cells against neurotoxins for 
dopaminergic neurons [21]. Our finding that BDNF- 
responsive SH-SYSY cells express trkB transcripts is in 
contrast to previous reports which failed to detect trkB 
in these cells [I 5.181. This discrepancy might be ex- 
plained by the use of the less sensitive Northern blot 
analysis rather than RT-PCR methodology, or by heter- 
ogeneity in SH-SYSY clones, or differences in culture 
conditions. In the present study, we demonstrate that 
retinoids and CAMP analogs up-regulate LNGFR ex- 
pression in SH-SYSY cells. Retinoic acid has consis- 
tently been shown to increase the expression of LNGFR 
in other cell types, including LA-N-l neuroblastoma 
cells [31], PC12 cells [32] and Sertoli cell line TM4 [33]. 
Data on the regulation of LNGFR by CAMP are more 
controversial. While it has been reported that CAMP 
down-regulated axotomy-induced LNGFR expression 
of Schwann cells [34], other studies [35] have described 
a CAMP-independent regulation of LNGFR in the same 
cells. Further investigations will be required to deter- 
mine the precise role of adenylate cyclase in the regula- 
tion of the LNGFR gene expression. 
Our finding that retinoids and CAMP analogs in- 
duced down-regulation of trkB expression in SH-SYSY 
cells could reflect a decrease in the sensitivity of differ- 
entiated SH-SYSY cells to BDNF. Although the role of 
the LNGFR is still not fully understood, it is possible 
that in some cells it serves as a common component for 
more than one functional neurotrophin receptor. Thus, 
differentiated SH-SYSY cells, in which trkB expression 
is reduced, might still contain trk and trkC, the essential 
components for binding and responding to other mem- 
bers of the NGF family of neutrophins. It will be of 
interest to examine whether trk and trkC, the functional 
receptors for NGF and neurotrophin-3 respectively, are 
expressed in differentiated SH-SYSY cells. It is also 
possible that LNGFR may act in a pathway not involv- 
ing trk tyrosine kinases. 
3 
1 
- LNGFR ** 
* trkB 
T 
2- 
l- 
** * P 
‘-c,,__q 
O-i----t' 
0 1 10 loo loo0 
dbcAMP (PM) 
Fig 6. Effects of dbcAMP on the expression of LNGFR and trkB 
mRNA m SH-SYSY cells. Cells were cultured for 72 h in the presence 
of the indicated concentrations of dbcAMP. Samples were processed 
for RT-PCR as described in Fig 1. Results are means t S.E.M. of 
three independent determinations, each done in duplicate 
(**Pi 0.002; *P < 0.02). 
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Our results suggest that neuronal differentiation in- 
cludes modulation of the expression of cell surface neu- 
rotrophin receptors. Consistent with this hypothesis, 
basic fibroblast growth factor was found to initiate neu- 
ronal differentiation of a sympathoadrenal progenitor 
cell line and to induce expression of LNGFR [36]. 
In the present study. we have shown that the SH- 
SYSY neuroblastoma cell line is a suitable model for the 
study of the regulation of BDNF receptors. This cell 
line now provides an opportunity for manipulation and 
analysis of the BDNF receptor signaling pathway. 
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